|
ISIN No
|
INE935A01035
|
BSE Code / NSE Code
|
532296 / GLENMARK
|
Book Value (Rs.)
|
389.58
|
Face Value
|
1.00
|
|
Bookclosure
|
31/08/2026
|
52Week High
|
2538
|
EPS
|
48.25
|
P/E
|
47.66
|
|
Market Cap.
|
64911.67 Cr.
|
52Week Low
|
1793
|
P/BV / Div Yield (%)
|
5.90 / 0.22
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Glenmark Holdings SA
| Equity Share | Subsidiary | 14323.18 |
| 2603 |
Glenmark Pharmaceuticals Mexico SA DE CV
| Equity Share | Subsidiary | 169.53 |
| 2603 |
Glenmark Impex LLC
| Equity Share | Subsidiary | 143.56 |
| 2603 |
Glenmark South Africa (Pty) Ltd.
| Equity Share | Subsidiary | 104.42 |
| 2603 |
Glenmark Pharmaceuticals Peru SAC
| Equity Share | Subsidiary | 82.78 |
| 2603 |
Glenmark Uruguay SA
| Equity Share | Subsidiary | 77.45 |
| 2603 |
Glenmark Pharmaceuticals Egypt SAE
| Equity Share | Subsidiary | 63.43 |
| 2603 |
Glenmark Pharmaceuticals Europe Ltd., U.K.
| Equity Share | Subsidiary | 57.82 |
|